pharma · Decompensated Cirrhosis · Primary Ovarian Insufficiency
Shanghai Institute of
Chinese Academy of Sciences
Chinese Academy of is a pharma organization headquartered in CN. Primary therapeutic focus areas include Decompensated Cirrhosis, Primary Ovarian Insufficiency. NovaPharmaNews links 2 clinical program(s), 0 drug profile(
CN HQ
114 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Employees
- 114
- Programs
- 2
- Drugs
- 4
- Patents
- 0
Conventional therapy
Phase 2 · mab · Decompensated Cirrhosis
Conventional therapy for Decompensated Cirrhosis is a Phase 2 program (mab) at Chinese Academy of Sciences with 1 ClinicalTrials.gov record(s).
Internal code CAS-XDA-DC/IGDB
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Chinese Academy of Sciences
- Phase
- Phase 2
- Modality
- mab
- Indication
- Decompensated Cirrhosis
- Status
- active
- Trials
- 1